Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1165]

Is lung cancer screening ready for implementation in Europe?

Dr Giulia Veronesi - Humanitas Research Hospital, Milan, Italy

Is lung cancer screening ready for implementation in Europe? ( Dr Giulia Veronesi - Humanitas Research Hospital, Milan, Italy )

What is the potential for using monoclonal antibodies in multiple myeloma?

Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel

What is the potential for using monoclonal antibodies in multiple myeloma? ( Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel )

Surgery in synchronous oligometastatic disease

Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden

Surgery in synchronous oligometastatic disease ( Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden )

Results of a placebo controlled study of tasquinimod in men with metastatic...

Dr Michael A. Carducci - Johns Hopkins University, Baltimore, USA

Results of a placebo controlled study of tasquinimod in men with metastatic castrate resistant prostate cancer ( Dr Michael A. Carducci - Johns Hopkins University, Baltimore, USA )

Brain metastases genomic analysis could reveal new targets for treatment

Prof Priscilla Brastianos - Massachusetts General Hospital, Boston, USA

Brain metastases genomic analysis could reveal new targets for treatment ( Prof Priscilla Brastianos - Massachusetts General Hospital, Boston, USA )

Examining NSCLC responses to durvalumab monotherapy

Brandon Higgs - MedImmune, Gaithersburg, USA

Examining NSCLC responses to durvalumab monotherapy ( Brandon Higgs - MedImmune, Gaithersburg, USA )

Watchful waiting versus neck dissection in patients with head and neck cancers

Prof Hisham Mehanna - University of Birmingham, Birmingham, UK

Watchful waiting versus neck dissection in patients with head and neck cancers ( Prof Hisham Mehanna - University of Birmingham, Birmingham, UK )

PD-L2 expression and its relevance to anti-PD-1 therapy in cancer

Dr Jennifer Yearley - Merck Research Labs, Biologics Discovery, Palo Alto, USA

PD-L2 expression and its relevance to anti-PD-1 therapy in cancer ( Dr Jennifer Yearley - Merck Research Labs, Biologics Discovery, Palo Alto, USA )

Prostate highlights from ECC 2015

Prof Noel Clarke and Dr Bertrand Tombal

Prostate highlights from ECC 2015 ( Prof Noel Clarke and Dr Bertrand Tombal )

Genetic screening of brain metastases could reveal new targets for treatment

Prof Priscilla Brastianos - Massachusetts General Hospital, Boston, USA

Genetic screening of brain metastases could reveal new targets for treatment ( Prof Priscilla Brastianos - Massachusetts General Hospital, Boston, USA )

Comment: New immunotherapy options for kidney cancer

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium

Comment: New immunotherapy options for kidney cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )

Cytogenetic and proteomic prognostic markers of CLL

Dr Lauren Thurgood - Flinders University, Adelaide, South Australia

Cytogenetic and proteomic prognostic markers of CLL ( Dr Lauren Thurgood - Flinders University, Adelaide, South Australia )

More from ecancer